000 | 01889 a2200493 4500 | ||
---|---|---|---|
005 | 20250513192110.0 | ||
264 | 0 | _c19991004 | |
008 | 199910s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHu, X | |
245 | 0 | 0 |
_aTNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cSep 1999 |
||
300 |
_a3106-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aADP-ribosyl Cyclase |
650 | 0 | 4 | _aADP-ribosyl Cyclase 1 |
650 | 0 | 4 |
_aAntigens, CD _xphysiology |
650 | 0 | 4 |
_aAntigens, CD34 _xbiosynthesis |
650 | 0 | 4 |
_aAntigens, Differentiation _xbiosynthesis |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _ximmunology |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 | _aClone Cells |
650 | 0 | 4 |
_aEnzyme Activation _ximmunology |
650 | 0 | 4 |
_aGrowth Inhibitors _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Erythroblastic, Acute _ximmunology |
650 | 0 | 4 | _aMembrane Glycoproteins |
650 | 0 | 4 |
_aNAD+ Nucleosidase _xbiosynthesis |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 | _aNecrosis |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xphysiology |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type I |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type II |
650 | 0 | 4 |
_aSignal Transduction _ximmunology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xphysiology |
700 | 1 | _aTang, M | |
700 | 1 | _aFisher, A B | |
700 | 1 | _aOlashaw, N | |
700 | 1 | _aZuckerman, K S | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 163 _gno. 6 _gp. 3106-15 |
|
999 |
_c10435006 _d10435006 |